FINWIRES · TerminalLIVE
FINWIRES

Wells Fargo Downgrades Boston Scientific to Equalweight From Overweight, Adjusts PT to $55 From $75

By

Boston Scientific (BSX) has an average rating of buy and mean price target of $81.57, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles